已收录 270995 条政策
 政策提纲
  • 暂无提纲
Buprenorphine/Naloxone Treatment in the Correctional Setting: Use or Misuse
[摘要] Over 50 percent of the incarcerated population in the United States have a history substance abuse, and it has been noted that over 200,000 of the incarcerated population have a heroin addiction history.1 In a study by Nunn et al,1 in which all 50 states and the District of Columbia were surveyed, 55 percent of the 51 prisons in the survey prescribed methadone to the inmates and 14 percent prescribed buprenorphine. The main reason cited for not offering opiate replacement therapy (methadone or buprenorphine/naloxone) was that a “drug-free detoxification” was preferred.1
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 精神健康和精神病学
[关键词]  [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文